Clinical trials
Phase 3 Kidney Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Arcus Biosciences, Inc. | 1 |
| AstraZeneca | 1 |
| Incheon St.Mary's Hospital | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Samsung Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 9 |
| Carcinoma, Renal Cell | 4 |
| Kidney Diseases | 2 |
| Adenocarcinoma | 1 |
| Carcinoma | 1 |
| Neoplasms | 1 |
| Neoplasms by Site | 1 |
| Prostatic Neoplasms | 1 |
| Urogenital Neoplasms | 1 |
| Urologic Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.